TP53 and ductal breast carcinoma in situ: To further evaluate the function of transcriptional factor SREBF2 in the TP53 mutation group and DCIS, we performed GSEA using the target genes (TGs) of SREBF2 from the ENCODE transcription factor targets dataset[32] (Table S3, Supporting Information).